(PG) Procter & Gamble - Ratings and Ratios
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US7427181091
Shampoo, Deodorant, Razor, Toothpaste, Detergent, Diaper
Dividends
| Dividend Yield | 2.99% |
| Yield on Cost 5y | 3.49% |
| Yield CAGR 5y | 6.16% |
| Payout Consistency | 94.7% |
| Payout Ratio | 60.6% |
| Risk via 10d forecast | |
|---|---|
| Volatility | 20.3% |
| Value at Risk 5%th | 33.5% |
| Relative Tail Risk | 0.23% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -1.07 |
| Alpha | -23.29 |
| CAGR/Max DD | -0.02 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.322 |
| Beta | 0.162 |
| Beta Downside | 0.153 |
| Drawdowns 3y | |
|---|---|
| Max DD | 20.97% |
| Mean DD | 5.41% |
| Median DD | 4.59% |
Description: PG Procter & Gamble December 02, 2025
The Procter & Gamble Company (PG) is a global consumer-packaged-goods leader that sells a broad portfolio of branded products across five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. Its well-known brands include Head & Shoulders, Olay, Gillette, Crest, Tide, Pampers and many others, covering everything from shampoos and razors to diapers and household cleaners.
PG reaches consumers through an extensive distribution network that spans mass merchandisers, grocery and specialty beauty stores, drug and department stores, e-commerce platforms, membership clubs, wholesale distributors, airport duty-free outlets and direct-to-consumer channels. This omnichannel footprint supports its status as a defensive staple with stable demand even during economic downturns.
In FY 2023 the company generated $80.2 billion in net sales, delivering a 5 % year-over-year growth rate and an operating margin of roughly 18 %. Strong cash flow ($15 billion) enabled a $7 billion share-repurchase program and a dividend yield near 2.5 %. Key sector drivers include inflation-linked pricing power, ongoing cost-saving initiatives, and rising demand for sustainable and health-focused products in both mature and emerging markets.
For a deeper quantitative breakdown, the ValueRay platform offers a granular view of PG’s valuation metrics and peer comparisons.
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income (16.77b TTM) > 0 and > 6% of Revenue (6% = 5.10b TTM) |
| FCFTA 0.12 (>2.0%) and ΔFCFTA -1.81pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -12.81% (prev -10.69%; Δ -2.11pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.15 (>3.0%) and CFO 18.92b > Net Income 16.77b (YES >=105%, WARN >=100%) |
| Net Debt (24.77b) to EBITDA (24.81b) ratio: 1.00 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.71 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (2.44b) change vs 12m ago -1.18% (target <= -2.0% for YES) |
| Gross Margin 50.98% (prev 51.41%; Δ -0.43pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 66.86% (prev 66.34%; Δ 0.52pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 25.32 (EBITDA TTM 24.81b / Interest Expense TTM 866.0m) >= 6 (WARN >= 3) |
Altman Z'' 5.74
| (A) -0.09 = (Total Current Assets 27.12b - Total Current Liabilities 37.99b) / Total Assets 127.60b |
| (B) 1.04 = Retained Earnings (Balance) 132.21b / Total Assets 127.60b |
| warn (B) unusual magnitude: 1.04 — check mapping/units |
| (C) 0.17 = EBIT TTM 21.93b / Avg Total Assets 127.04b |
| (D) 1.68 = Book Value of Equity 124.06b / Total Liabilities 74.05b |
| Total Rating: 5.74 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 82.59
| 1. Piotroski 6.0pt |
| 2. FCF Yield 4.14% |
| 3. FCF Margin 17.59% |
| 4. Debt/Equity 0.67 |
| 5. Debt/Ebitda 1.00 |
| 6. ROIC - WACC (= 14.14)% |
| 7. RoE 32.13% |
| 8. Rev. Trend 49.15% |
| 9. EPS Trend 47.77% |
What is the price of PG shares?
As of December 11, 2025, the stock is trading at USD 139.82 with a total of 13,457,922 shares traded.
Over the past week, the price has changed by -4.70%, over one month by -3.90%, over three months by -10.52% and over the past year by -16.68%.
Over the past week, the price has changed by -4.70%, over one month by -3.90%, over three months by -10.52% and over the past year by -16.68%.
Is PG a buy, sell or hold?
Procter & Gamble has received a consensus analysts rating of 4.04.
Therefore, it is recommended to buy PG.
- Strong Buy: 11
- Buy: 5
- Hold: 8
- Sell: 1
- Strong Sell: 0
What are the forecasts/targets for the PG price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 169.1 | 20.9% |
| Analysts Target Price | 169.1 | 20.9% |
| ValueRay Target Price | 130.5 | -6.7% |
PG Fundamental Data Overview December 06, 2025
Market Cap USD = 335.74b (335.74b USD * 1.0 USD.USD)
P/E Trailing = 20.9416
P/E Forward = 20.7469
P/S = 3.953
P/B = 6.4699
P/EG = 4.4182
Beta = 0.382
Revenue TTM = 84.93b USD
EBIT TTM = 21.93b USD
EBITDA TTM = 24.81b USD
Long Term Debt = 24.32b USD (from longTermDebt, last quarter)
Short Term Debt = 11.63b USD (from shortTermDebt, last quarter)
Debt = 35.95b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 24.77b USD (from netDebt column, last quarter)
Enterprise Value = 360.52b USD (335.74b + Debt 35.95b - CCE 11.17b)
Interest Coverage Ratio = 25.32 (Ebit TTM 21.93b / Interest Expense TTM 866.0m)
FCF Yield = 4.14% (FCF TTM 14.94b / Enterprise Value 360.52b)
FCF Margin = 17.59% (FCF TTM 14.94b / Revenue TTM 84.93b)
Net Margin = 19.74% (Net Income TTM 16.77b / Revenue TTM 84.93b)
Gross Margin = 50.98% ((Revenue TTM 84.93b - Cost of Revenue TTM 41.63b) / Revenue TTM)
Gross Margin QoQ = 51.37% (prev 49.11%)
Tobins Q-Ratio = 2.83 (Enterprise Value 360.52b / Total Assets 127.60b)
Interest Expense / Debt = 0.55% (Interest Expense 197.0m / Debt 35.95b)
Taxrate = 20.77% (1.25b / 6.03b)
NOPAT = 17.37b (EBIT 21.93b * (1 - 20.77%))
Current Ratio = 0.71 (Total Current Assets 27.12b / Total Current Liabilities 37.99b)
Debt / Equity = 0.67 (Debt 35.95b / totalStockholderEquity, last quarter 53.27b)
Debt / EBITDA = 1.00 (Net Debt 24.77b / EBITDA 24.81b)
Debt / FCF = 1.66 (Net Debt 24.77b / FCF TTM 14.94b)
Total Stockholder Equity = 52.18b (last 4 quarters mean from totalStockholderEquity)
RoA = 13.14% (Net Income 16.77b / Total Assets 127.60b)
RoE = 32.13% (Net Income TTM 16.77b / Total Stockholder Equity 52.18b)
RoCE = 28.66% (EBIT 21.93b / Capital Employed (Equity 52.18b + L.T.Debt 24.32b))
RoIC = 20.15% (NOPAT 17.37b / Invested Capital 86.22b)
WACC = 6.01% (E(335.74b)/V(371.69b) * Re(6.61%) + D(35.95b)/V(371.69b) * Rd(0.55%) * (1-Tc(0.21)))
Discount Rate = 6.61% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: -100.0 | Cagr: -0.64%
[DCF Debug] Terminal Value 78.72% ; FCFE base≈15.80b ; Y1≈16.28b ; Y5≈18.34b
Fair Price DCF = 138.1 (DCF Value 322.62b / Shares Outstanding 2.34b; 5y FCF grow 3.03% → 3.0% )
EPS Correlation: 47.77 | EPS CAGR: 4.95% | SUE: 1.82 | # QB: 2
Revenue Correlation: 49.15 | Revenue CAGR: 1.78% | SUE: 0.87 | # QB: 1
EPS next Quarter (2026-03-31): EPS=1.59 | Chg30d=-0.004 | Revisions Net=-3 | Analysts=17
EPS current Year (2026-06-30): EPS=7.00 | Chg30d=+0.000 | Revisions Net=+6 | Growth EPS=+2.5% | Growth Revenue=+3.2%
EPS next Year (2027-06-30): EPS=7.39 | Chg30d=+0.000 | Revisions Net=-5 | Growth EPS=+5.5% | Growth Revenue=+3.0%
P/E Trailing = 20.9416
P/E Forward = 20.7469
P/S = 3.953
P/B = 6.4699
P/EG = 4.4182
Beta = 0.382
Revenue TTM = 84.93b USD
EBIT TTM = 21.93b USD
EBITDA TTM = 24.81b USD
Long Term Debt = 24.32b USD (from longTermDebt, last quarter)
Short Term Debt = 11.63b USD (from shortTermDebt, last quarter)
Debt = 35.95b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 24.77b USD (from netDebt column, last quarter)
Enterprise Value = 360.52b USD (335.74b + Debt 35.95b - CCE 11.17b)
Interest Coverage Ratio = 25.32 (Ebit TTM 21.93b / Interest Expense TTM 866.0m)
FCF Yield = 4.14% (FCF TTM 14.94b / Enterprise Value 360.52b)
FCF Margin = 17.59% (FCF TTM 14.94b / Revenue TTM 84.93b)
Net Margin = 19.74% (Net Income TTM 16.77b / Revenue TTM 84.93b)
Gross Margin = 50.98% ((Revenue TTM 84.93b - Cost of Revenue TTM 41.63b) / Revenue TTM)
Gross Margin QoQ = 51.37% (prev 49.11%)
Tobins Q-Ratio = 2.83 (Enterprise Value 360.52b / Total Assets 127.60b)
Interest Expense / Debt = 0.55% (Interest Expense 197.0m / Debt 35.95b)
Taxrate = 20.77% (1.25b / 6.03b)
NOPAT = 17.37b (EBIT 21.93b * (1 - 20.77%))
Current Ratio = 0.71 (Total Current Assets 27.12b / Total Current Liabilities 37.99b)
Debt / Equity = 0.67 (Debt 35.95b / totalStockholderEquity, last quarter 53.27b)
Debt / EBITDA = 1.00 (Net Debt 24.77b / EBITDA 24.81b)
Debt / FCF = 1.66 (Net Debt 24.77b / FCF TTM 14.94b)
Total Stockholder Equity = 52.18b (last 4 quarters mean from totalStockholderEquity)
RoA = 13.14% (Net Income 16.77b / Total Assets 127.60b)
RoE = 32.13% (Net Income TTM 16.77b / Total Stockholder Equity 52.18b)
RoCE = 28.66% (EBIT 21.93b / Capital Employed (Equity 52.18b + L.T.Debt 24.32b))
RoIC = 20.15% (NOPAT 17.37b / Invested Capital 86.22b)
WACC = 6.01% (E(335.74b)/V(371.69b) * Re(6.61%) + D(35.95b)/V(371.69b) * Rd(0.55%) * (1-Tc(0.21)))
Discount Rate = 6.61% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: -100.0 | Cagr: -0.64%
[DCF Debug] Terminal Value 78.72% ; FCFE base≈15.80b ; Y1≈16.28b ; Y5≈18.34b
Fair Price DCF = 138.1 (DCF Value 322.62b / Shares Outstanding 2.34b; 5y FCF grow 3.03% → 3.0% )
EPS Correlation: 47.77 | EPS CAGR: 4.95% | SUE: 1.82 | # QB: 2
Revenue Correlation: 49.15 | Revenue CAGR: 1.78% | SUE: 0.87 | # QB: 1
EPS next Quarter (2026-03-31): EPS=1.59 | Chg30d=-0.004 | Revisions Net=-3 | Analysts=17
EPS current Year (2026-06-30): EPS=7.00 | Chg30d=+0.000 | Revisions Net=+6 | Growth EPS=+2.5% | Growth Revenue=+3.2%
EPS next Year (2027-06-30): EPS=7.39 | Chg30d=+0.000 | Revisions Net=-5 | Growth EPS=+5.5% | Growth Revenue=+3.0%
Additional Sources for PG Stock
News:
Wall Street Journal |
Benzinga |
Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle